Oncotelic Therapeutics, Inc. Equity Securities, FV-NI, Cost
Oncotelic Therapeutics, Inc. (OTLC) had Equity Securities, FV-NI, Cost of $389.10 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:EquitySecuritiesFvNiCost · last filed 2026-08-13
- 2026-06-30: Equity Securities, FV-NI, Cost $389.10M.
- 2025-12-31: Equity Securities, FV-NI, Cost $22.65M.
| Period end | Equity Securities, FV-NI, Cost |
|---|---|
| 2026-06-30 | $389.10M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $22.65M 10-Q · filed 2026-08-13 |